Correlation Between Sarepta Therapeutics and Pmv Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Sarepta Therapeutics and Pmv Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sarepta Therapeutics and Pmv Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Sarepta Therapeutics and Pmv Pharmaceuticals, you can compare the effects of market volatilities on Sarepta Therapeutics and Pmv Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sarepta Therapeutics with a short position of Pmv Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sarepta Therapeutics and Pmv Pharmaceuticals.

Diversification Opportunities for Sarepta Therapeutics and Pmv Pharmaceuticals

0.02

Correlation Coefficient

Sarepta Therapeutics  Pmv Pharmaceuticals

Significant diversification

The 3 months correlation between Sarepta and Pmv is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Sarepta Therapeutics and Pmv Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pmv Pharmaceuticals and Sarepta Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sarepta Therapeutics are associated (or correlated) with Pmv Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pmv Pharmaceuticals has no effect on the direction of Sarepta Therapeutics i.e., Sarepta Therapeutics and Pmv Pharmaceuticals go up and down completely randomly.

Pair Corralation between Sarepta Therapeutics and Pmv Pharmaceuticals

Given the investment horizon of 90 days Sarepta Therapeutics is expected to generate 0.86 times more return on investment than Pmv Pharmaceuticals. However, Sarepta Therapeutics is 1.17 times less risky than Pmv Pharmaceuticals. It trades about 0.06 of its potential returns per unit of risk. Pmv Pharmaceuticals is currently generating about -0.03 per unit of risk. If you would invest  8,306  in Sarepta Therapeutics on September 14, 2024 and sell it today you would earn a total of  4,072  from holding Sarepta Therapeutics or generate 49.02% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Sarepta Therapeutics  vs.  Pmv Pharmaceuticals

Sarepta Therapeutics

Risk-Adjusted Performance

0 of 100

Weak

Over the last 90 days Sarepta Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Sarepta Therapeutics is not utilizing all of its potentials. The recent stock price uproar, may contribute to short-horizon losses for the private investors.

Pmv Pharmaceuticals

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Pmv Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent basic indicators, Pmv Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Sarepta Therapeutics and Pmv Pharmaceuticals

The main advantage of trading using opposite Sarepta Therapeutics and Pmv Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sarepta Therapeutics position performs unexpectedly, Pmv Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pmv Pharmaceuticals will offset losses from the drop in Pmv Pharmaceuticals' long position.

The idea behind Sarepta Therapeutics and Pmv Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.